Les tests de dépistage de la Covid-19 : comment la Chine a évalué les tests en urgence ? (notice n° 271017)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02430cam a2200313 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250112080443.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Ju, Liya |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Les tests de dépistage de la Covid-19 : comment la Chine a évalué les tests en urgence ? |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2020.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 52 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | RésuméDe nombreux tests moléculaires et sérologiques pour la détection de l’ARN virale du SARS-CoV-2 et des anticorps associés ont été développés très tôt en Chine, pour répondre en urgence aux besoins vitaux pour poser le diagnostic de la Covid-19. Un groupe de travail a été rapidement constitué pour vérifier et évaluer la sensibilité et la spécificité de sept différents kits de détection d’ARN virale par RT-PCR. Nous discutons de leurs performances, des gènes ciblés et de leurs limites de détection. Par ailleurs, des kits sérologiques commercialisés par sept sociétés pour la détection des IgG/IgM ont été également évalués en Chine et sont aujourd’hui disponibles en complément des kits moléculaires pour le diagnostic de la Covid-19. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Numerous molecular and serological tests for the detection of viral RNA and associated antibodies of SARS-CoV-2 were developed at an early stage in China in order to respond urgently to the basic need to diagnose Covid-19. A working group was quickly set up to check and assess the sensitivity and specificity of seven different viral RNA detection kits based on RT-PCR. We discuss their performance, target genes and limit of detection. In addition, serological kits marketed by seven companies for the detection of IgG/IgM have also been evaluated in China and are now available in addition to the molecular kits for the diagnosis of Covid-19. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | test sérologique |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | PCR en temps réel |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | tests ADN |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Covid-19 |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | évaluation de performance |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | real time RT-PCR |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | serological test |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | evaluation of performance |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Covid-19 |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Armand, Marie-Anne |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zhang, Xiuming |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Griscelli, Frank |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Innovations & Thérapeutiques en Oncologie | Volume 6 | 2 | 2020-03-01 | p. 64-73 | 2431-3203 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-innovations-et-therapeutiques-en-oncologie-2020-2-page-64?lang=fr">https://shs.cairn.info/revue-innovations-et-therapeutiques-en-oncologie-2020-2-page-64?lang=fr</a> |
Pas d'exemplaire disponible.
Réseaux sociaux